What Is CJC-1295?

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). It works by stimulating the pituitary gland to produce growth hormone naturally, preserving the body's feedback mechanisms and pulsatile secretion pattern. Available in two forms (with DAC for extended release or without DAC as Mod GRF 1-29), it is one of the most commonly prescribed peptides for GH optimization in clinical practice.

CJC-1295 is frequently combined with ipamorelin to enhance GH release. The resulting increase in GH and its downstream mediator IGF-1 has systemic effects that extend well beyond muscle and metabolism, including meaningful interactions with the immune system.

How Growth Hormone Influences the Immune System

Growth hormone is not typically discussed as an immune molecule, but its effects on immune function are substantial and well-researched. GH receptors are expressed on virtually every type of immune cell, and GH signaling plays a role at multiple levels of immune defense.

Thymus Function and T-Cell Production

The thymus gland is responsible for producing and maturing T cells, the immune cells that coordinate adaptive immunity and directly destroy infected or abnormal cells. The thymus naturally shrinks with age (a process called thymic involution), which is one reason immune function declines as we get older.

Growth hormone has been shown to stimulate thymic regeneration and increase T-cell production. Studies in both animal models and GH-deficient humans demonstrate that GH can partially reverse thymic involution and restore T-cell output.

By raising GH levels, CJC-1295 may support the thymus's ability to produce immune cells, potentially slowing one of the key mechanisms of age-related immune decline (immunosenescence).

Natural Killer Cell Activity

Natural killer (NK) cells are immune cells that provide rapid, innate defense against viruses and abnormal cells. Research shows that GH enhances NK cell activity. Patients with growth hormone deficiency show reduced NK cell function, which improves with GH replacement therapy.

Immune Cell Proliferation

GH and IGF-1 support the proliferation of lymphocytes (both T cells and B cells). IGF-1, which CJC-1295 raises through GH stimulation, acts as a survival and growth factor for immune cells, helping them multiply in response to threats and maintain adequate populations during periods between infections.

Inflammatory Balance

GH helps modulate the balance between pro-inflammatory and anti-inflammatory immune responses. Rather than simply boosting all immune activity (which could worsen autoimmune conditions), GH supports appropriate immune regulation. This is relevant because chronic, low-grade inflammation is itself a form of immune dysregulation that GH optimization may help correct.

Dosing and Administration

Standard CJC-1295 dosing protocols for GH optimization, which may support immune function:

• CJC-1295 with DAC: 1 to 2 mg subcutaneously once or twice per week.
• CJC-1295 without DAC (Mod GRF 1-29): 100 to 300 mcg subcutaneously 1 to 3 times daily.
• Combined with ipamorelin: Dosed as directed by the prescribing physician for synergistic GH release.

There is no specific immune-support dosing protocol for CJC-1295. Immune benefits are considered secondary to GH optimization at standard doses. For complete dosing information, see our CJC-1295 dosage guide.

Benefits and Expected Results

Immune function improvements from GH optimization are not immediately measurable in the way that energy or sleep changes are. Expected timelines based on GH and immune research:

• Week 1 to 4: Improved sleep quality supports overnight immune processes. Better rest enhances the body's nightly immune surveillance and repair activities.
• Month 1 to 3: GH and IGF-1 levels stabilize at optimized ranges. Immune cell production may begin to increase. Some patients report fewer minor illnesses or faster recovery from colds and infections, though this is anecdotal.
• Month 3 to 6: More sustained immune support as thymic function and immune cell populations respond to improved GH signaling. Inflammatory markers may improve on follow-up blood work.
• Month 6 and beyond: Long-term GH optimization may contribute to slower immunosenescence, helping maintain more youthful immune function over time.

Immune benefits are difficult to quantify on a day-to-day basis. The most practical measure is overall resilience: getting sick less often, recovering faster when you do, and maintaining consistent health.

Side Effects and Safety

CJC-1295 is well-tolerated under physician supervision. Common side effects are mild:

• Injection site reactions
• Mild headache
• Facial flushing
• Temporary water retention
• Occasional tingling in extremities

An important safety consideration for immune-related use: CJC-1295 should not be used during active infections, as the effects of acutely elevating GH during an active immune response are not well-characterized. GH optimization is a baseline-building strategy, not an acute treatment for illness.

Patients with autoimmune conditions should discuss CJC-1295 with both their prescribing physician and their rheumatologist or immunologist, as GH's effects on immune regulation could theoretically influence autoimmune activity in either direction.

Contraindications include active cancer, pregnancy, and breastfeeding. See our CJC-1295 side effects guide for full safety information.

Who Is a Good Candidate?

CJC-1295 for immune support may be particularly relevant for:

• Adults over 40 who have noticed increased susceptibility to illness, slower recovery from infections, or general immune decline alongside other symptoms of GH insufficiency
• Individuals with blood work showing low IGF-1 levels in conjunction with markers of immune decline
• Patients interested in addressing age-related immune decline (immunosenescence) as part of a comprehensive wellness strategy
• Those who want to support immune resilience through hormonal optimization rather than relying solely on supplements or reactive treatments

CJC-1295 is not a substitute for vaccines, antimicrobial treatments, or medical management of immunodeficiency conditions. It is a systemic optimization tool that may support the immune system's overall baseline function.

Frequently Asked Questions

Can CJC-1295 prevent illness?

CJC-1295 is not a preventive treatment for any specific illness. By supporting immune function through GH optimization, it may help your body maintain stronger baseline defenses, but it does not replace vaccines, hygiene practices, or other preventive measures.

Is CJC-1295 safe for people with autoimmune conditions?

This requires careful individual assessment. GH modulates immune function, which could theoretically influence autoimmune activity. Patients with autoimmune conditions should consult with both a peptide-prescribing physician and their immunologist or rheumatologist before starting CJC-1295.

How does CJC-1295 compare to thymosin alpha-1 for immune support?

They work through different mechanisms. Thymosin alpha-1 directly modulates immune cell function and is specifically studied as an immune-enhancing peptide. CJC-1295 supports immunity indirectly through GH and IGF-1 optimization. Some physicians use both in combination for comprehensive immune support, though this approach should be carefully monitored.

Does CJC-1295 help with recovery from surgery or illness?

GH is a key driver of tissue repair and recovery. CJC-1295 may support recovery through enhanced healing processes. However, the timing of use around acute illness or surgery should be discussed with your physician, as GH-stimulating therapies are generally best used as baseline optimization rather than acute interventions.